Biogenes Technologies is trying to change the biotech landscape by creating and commercialising synthetic antibodies for mass use in all kinds of test kits. However building and scaling a deeptech startup like this can be challenging here in Malaysia without the right help.

We speak to Adrian Joseph, Co-Founder & Chief Commercial Officer, of Biogenes Technologies about the startup’s journey and mission, and how Cradle Fund has supported them along the way.